Jump to content

Molecular Computing Patent Application Trends 2025: Difference between revisions

From WikiPatents
← Older edit
Updating Molecular Computing Patent Application Trends 2025
Updating Molecular Computing Patent Application Trends 2025
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
== Molecular Computing Patent Application Filing Activity ==
== Molecular Computing Patent Application Filing Activity ==
== Molecular Computing patent applications in 2025 ==
== Molecular Computing patent applications in 2025 ==
[[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_February 2025.png|border|800px]]
[[File:Molecular_Computing_Monthly_Patent_Applications_2025_-_Up_to_May 2025.png|border|800px]]


== Top Technology Areas in Molecular Computing ==
== Top Technology Areas in Molecular Computing ==
[[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_February 2025.png|border|800px]]
[[File:Top_Technology_Areas_in_Molecular_Computing_2025_-_Up_to_May 2025.png|border|800px]]


=== Top CPC Codes ===
=== Top CPC Codes ===
* [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available)
* [[:Category:CPC_A61K39/4611|A61K39/4611]] ({Cellular immunotherapy})
** Count: 5 patents
** Count: 5 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available)
* [[:Category:CPC_A61K39/4631|A61K39/4631]] ({Cellular immunotherapy})
** Count: 5 patents
** Count: 5 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_C07K14/7051|C07K14/7051]] (No explanation available)
* [[:Category:CPC_A61P35/00|A61P35/00]] (Antineoplastic agents)
** Count: 3 patents
** Count: 4 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available)
* [[:Category:CPC_C07K14/7051|C07K14/7051]] (PEPTIDES  (peptides in foodstuffs)
** Count: 3 patents
** Count: 3 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K2239/31|A61K2239/31]] (No explanation available)
* [[:Category:CPC_A61K2239/31|A61K2239/31]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K2239/38|A61K2239/38]] (No explanation available)
* [[:Category:CPC_A61K2239/38|A61K2239/38]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_A61K39/464412|A61K39/464412]] (No explanation available)
* [[:Category:CPC_A61K2239/47|A61K2239/47]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
** Example: [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]]
* [[:Category:CPC_C07K2317/92|C07K2317/92]] (No explanation available)
* [[:Category:CPC_A61K39/464412|A61K39/464412]] ({Cellular immunotherapy})
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2319/02|C07K2319/02]] (No explanation available)
* [[:Category:CPC_C07K2317/92|C07K2317/92]] (PEPTIDES  (peptides in foodstuffs)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
* [[:Category:CPC_C07K2319/03|C07K2319/03]] (No explanation available)
* [[:Category:CPC_C07K2319/02|C07K2319/02]] (PEPTIDES  (peptides in foodstuffs)
** Count: 2 patents
** Count: 2 patents
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
** Example: [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]]
Line 42: Line 42:


=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
* Number of Molecular Computing patents: 2
* Number of Molecular Computing patents: 3
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 2 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] ({Cellular immunotherapy}): 2 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 2 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] ({Cellular immunotherapy}): 2 patents
** [[:Category:CPC_C07K14/7051|C07K14/7051]] (No explanation available): 1 patents
** [[:Category:CPC_C07K14/7051|C07K14/7051]] (PEPTIDES  (peptides in foodstuffs): 1 patents
* Recent patents:
* Recent patents:
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
** [[20250034229. METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS (The Regents of the University of California)]] (20250130)
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
** [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]] (20250313)
=== [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]] ===
=== [[:Category:INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_A61K39/464402|A61K39/464402]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/464402|A61K39/464402]] ({Cellular immunotherapy}): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] ({Cellular immunotherapy}): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] ({Cellular immunotherapy}): 1 patents
* Recent patents:
* Recent patents:
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
** [[20250041416. P329G ANTIBODY TARGETING BCMA, COMBINATION OF SAME WITH CHIMERIC ANTIGEN RECEPTOR CELL, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.)]] (20250206)
Line 61: Line 62:
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C07K14/47|C07K14/47]] (No explanation available): 1 patents
** [[:Category:CPC_C07K14/47|C07K14/47]] (PEPTIDES  (peptides in foodstuffs): 1 patents
** [[:Category:CPC_A61K45/06|A61K45/06]] (No explanation available): 1 patents
** [[:Category:CPC_A61K45/06|A61K45/06]] (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
** [[:Category:CPC_A61K38/00|A61K38/00]] (No explanation available): 1 patents
** [[:Category:CPC_A61K38/00|A61K38/00]] (Medicinal preparations containing peptides  (peptides containing beta-lactam rings): 1 patents
* Recent patents:
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:CZ Biohub SF, LLC|CZ Biohub SF, LLC]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_C12N15/1072|C12N15/1072]] ({Differential gene expression library synthesis, e.g. subtracted libraries, differential screening}): 1 patents
** [[:Category:CPC_C12Q1/25|C12Q1/25]] (involving enzymes not classifiable in groups): 1 patents
** [[:Category:CPC_C12Q1/485|C12Q1/485]] ({involving kinase}): 1 patents
* Recent patents:
** [[20250129361. METHOD FOR MASSIVELY-PARALLEL SCREENING OF APTAMER SWITCHES (CZ Biohub SF, LLC)]] (20250424)
=== [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]] ===
=== [[:Category:THE GENERAL HOSPITAL CORPORATION|THE GENERAL HOSPITAL CORPORATION]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C07K14/4702|C07K14/4702]] (No explanation available): 1 patents
** [[:Category:CPC_C07K14/4702|C07K14/4702]] (PEPTIDES  (peptides in foodstuffs): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] ({Cellular immunotherapy}): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] ({Cellular immunotherapy}): 1 patents
* Recent patents:
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:University of Washington|University of Washington]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_A61K47/65|A61K47/65]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
** [[:Category:CPC_A61K47/6903|A61K47/6903]] (the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit): 1 patents
* Recent patents:
** [[20250135016. MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION (University of Washington)]] (20250501)
=== [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_A61K40/429|A61K40/429]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
** [[:Category:CPC_A61K35/17|A61K35/17]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
** [[:Category:CPC_A61K40/11|A61K40/11]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] ===
=== [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C12N15/52|C12N15/52]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/52|C12N15/52]] (Genes encoding for enzymes or proenzymes): 1 patents
** [[:Category:CPC_C12N1/20|C12N1/20]] (No explanation available): 1 patents
** [[:Category:CPC_C12N1/20|C12N1/20]] (Bacteria; Culture media therefor): 1 patents
** [[:Category:CPC_C12N9/0006|C12N9/0006]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/0006|C12N9/0006]] (Enzymes; Proenzymes; Compositions thereof  (preparations containing enzymes for cleaning teeth): 1 patents
* Recent patents:
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:DNA 2 Ascendancy AB|DNA 2 Ascendancy AB]] ===
* Number of Molecular Computing patents: 1
* Top CPC codes:
** [[:Category:CPC_G06F7/544|G06F7/544]] (for evaluating functions by calculation {(): 1 patents
** [[:Category:CPC_G06N99/007|G06N99/007]] ({Molecular computers, i.e. using inorganic molecules  (using biomolecules): 1 patents
* Recent patents:
** [[20250085924. METHOD FOR MOLECULAR COMPUTING (DNA 2 Ascendancy AB)]] (20250313)
=== [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]] ===
=== [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_A61K35/17|A61K35/17]] (No explanation available): 1 patents
** [[:Category:CPC_A61K35/17|A61K35/17]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] ({Cellular immunotherapy}): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4631|A61K39/4631]] ({Cellular immunotherapy}): 1 patents
* Recent patents:
* Recent patents:
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)
** [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]] (20250109)
Line 99: Line 130:
[[File:Emerging_Technology_Areas_in_Molecular_Computing.png|border|800px]]
[[File:Emerging_Technology_Areas_in_Molecular_Computing.png|border|800px]]


* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (No explanation available)
* [[:Category:CPC_C12N2740/15041|C12N2740/15041]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/22|A61K2239/22]] (No explanation available)
* [[:Category:CPC_A61K2239/21|A61K2239/21]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/21|A61K2239/21]] (No explanation available)
* [[:Category:CPC_A61K2239/17|A61K2239/17]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/17|A61K2239/17]] (No explanation available)
* [[:Category:CPC_A61K2239/13|A61K2239/13]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES  (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_A61K2239/13|A61K2239/13]] (No explanation available)
* [[:Category:CPC_C12N15/86|C12N15/86]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
* [[:Category:CPC_C07K16/28|C07K16/28]] (PEPTIDES  (peptides in foodstuffs)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
* [[:Category:CPC_C07K16/28|C07K16/28]] (No explanation available)
* [[:Category:CPC_G06N99/007|G06N99/007]] ({Molecular computers, i.e. using inorganic molecules  (using biomolecules)
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250085924. METHOD FOR MOLECULAR COMPUTING (DNA 2 Ascendancy AB)]]
* [[:Category:CPC_A61K35/17|A61K35/17]] (No explanation available)
* [[:Category:CPC_G06F7/544|G06F7/544]] (for evaluating functions by calculation {()
** Count: 1 patents
** Count: 1 patents
** Example: [[20250009801. COMBINATION OF MOLECULAR SWITCH REGULATION TYPE CHIMERIC ANTIGEN RECEPTOR CELL AND ANTIBODY, AND USE THEREOF (INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.)]]
** Example: [[20250085924. METHOD FOR MOLECULAR COMPUTING (DNA 2 Ascendancy AB)]]
* [[:Category:CPC_C12Y401/01005|C12Y401/01005]] (No explanation available)
* [[:Category:CPC_G01N33/6845|G01N33/6845]] ({Methods of identifying protein-protein interactions in protein mixtures})
** Count: 1 patents
** Count: 1 patents
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]]
** Example: [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]]
* [[:Category:CPC_C12Y401/01004|C12Y401/01004]] (No explanation available)
* [[:Category:CPC_C12N15/1055|C12N15/1055]] ({Protein x Protein interaction, e.g. two hybrid selection})
** Count: 1 patents
** Count: 1 patents
** Example: [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]]
** Example: [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]]


== Top Companies in Emerging Molecular Computing Technologies 2025==
== Top Companies in Emerging Molecular Computing Technologies 2025==
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]]
[[File:Top_Companies_in_Emerging_Molecular_Computing_Technologies.png|border|800px]]


* [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 8 patents
* [[:Category:INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.|INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.]]: 6 patents
* [[:Category:PRECIGEN, INC.|PRECIGEN, INC.]]: 2 patents
* [[:Category:The Regents of the University of California|The Regents of the University of California]]: 2 patents
* [[:Category:DNA 2 Ascendancy AB|DNA 2 Ascendancy AB]]: 2 patents


== Top Inventors in Molecular Computing ==
== Top Inventors in Molecular Computing ==
Line 269: Line 301:
* Recent patents:
* Recent patents:
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
** [[20250042957. DESIGNED REPEAT DOMAINS WITH DUAL BINDING SPECIFICITY AND THEIR USE (Molecular Partners AG)]] (20250206)
=== [[:Category:Hyongsok Soh|Hyongsok Soh of Palo Alto CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:CZ Biohub SF, LLC|CZ Biohub SF, LLC]]: 1 patents
* Recent patents:
** [[20250129361. METHOD FOR MASSIVELY-PARALLEL SCREENING OF APTAMER SWITCHES (CZ Biohub SF, LLC)]] (20250424)
=== [[:Category:Alexander M. Yoshikawa|Alexander M. Yoshikawa of Redwood City CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:CZ Biohub SF, LLC|CZ Biohub SF, LLC]]: 1 patents
* Recent patents:
** [[20250129361. METHOD FOR MASSIVELY-PARALLEL SCREENING OF APTAMER SWITCHES (CZ Biohub SF, LLC)]] (20250424)
=== [[:Category:Alexandra E. Rangel|Alexandra E. Rangel of Santa Clara CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:CZ Biohub SF, LLC|CZ Biohub SF, LLC]]: 1 patents
* Recent patents:
** [[20250129361. METHOD FOR MASSIVELY-PARALLEL SCREENING OF APTAMER SWITCHES (CZ Biohub SF, LLC)]] (20250424)
=== [[:Category:Amani Hariri|Amani Hariri of Stanford CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:CZ Biohub SF, LLC|CZ Biohub SF, LLC]]: 1 patents
* Recent patents:
** [[20250129361. METHOD FOR MASSIVELY-PARALLEL SCREENING OF APTAMER SWITCHES (CZ Biohub SF, LLC)]] (20250424)
=== [[:Category:Max Jan|Max Jan of Boston MA (US)]] ===
=== [[:Category:Max Jan|Max Jan of Boston MA (US)]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
Line 293: Line 349:
* Recent patents:
* Recent patents:
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
** [[20250074957. MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS (THE GENERAL HOSPITAL CORPORATION)]] (20250306)
=== [[:Category:Cole DeForest|Cole DeForest of Seattle WA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Washington|University of Washington]]: 1 patents
* Recent patents:
** [[20250135016. MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION (University of Washington)]] (20250501)
=== [[:Category:Barry Badeau|Barry Badeau of Seattle WA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Washington|University of Washington]]: 1 patents
* Recent patents:
** [[20250135016. MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION (University of Washington)]] (20250501)
=== [[:Category:Loic Deleyrolle|Loic Deleyrolle of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Duane Mitchell|Duane Mitchell of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Jianping Huang|Jianping Huang of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Linchun Jin|Linchun Jin of Gainesville FL (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:University of Florida Research Foundation, Incorporated|University of Florida Research Foundation, Incorporated]]: 1 patents
* Recent patents:
** [[20250170242. CHIMERIC LACTATE RECEPTOR ENGINEERED T CELLS (University of Florida Research Foundation, Incorporated)]] (20250529)
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] ===
=== [[:Category:Mark Anton HELD|Mark Anton HELD of Germantown MD (US)]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
Line 329: Line 421:
* Recent patents:
* Recent patents:
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
** [[20250027093. MOLECULAR SWITCHES (PRECIGEN, INC.)]] (20250123)
=== [[:Category:Taylor Hanh NGUYEN|Taylor Hanh NGUYEN of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]] (20250313)
=== [[:Category:Galen DODS|Galen DODS of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]] (20250313)
=== [[:Category:Hana EL-SAMAD|Hana EL-SAMAD of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]] (20250313)
=== [[:Category:Andrew H. NG|Andrew H. NG of San Francisco CA (US)]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:The Regents of the University of California|The Regents of the University of California]]: 1 patents
* Recent patents:
** [[20250084406. REVERSIBLE HETERODIMERIZING SYSTEMS AS EFFECTORS FOR FEEDBACK CONTROL (The Regents of the University of California)]] (20250313)
=== [[:Category:Ross D. KING|Ross D. KING]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:DNA 2 Ascendancy AB|DNA 2 Ascendancy AB]]: 1 patents
* Recent patents:
** [[20250085924. METHOD FOR MOLECULAR COMPUTING (DNA 2 Ascendancy AB)]] (20250313)
=== [[:Category:Konstantin KOROVIN|Konstantin KOROVIN]] ===
* Number of Molecular Computing patents: 1
* Top companies:
** [[:Category:DNA 2 Ascendancy AB|DNA 2 Ascendancy AB]]: 1 patents
* Recent patents:
** [[20250085924. METHOD FOR MOLECULAR COMPUTING (DNA 2 Ascendancy AB)]] (20250313)
=== [[:Category:Shengjie GUO|Shengjie GUO]] ===
=== [[:Category:Shengjie GUO|Shengjie GUO]] ===
* Number of Molecular Computing patents: 1
* Number of Molecular Computing patents: 1
Line 359: Line 487:


* Suzhou, Jiangsu: 13 inventors
* Suzhou, Jiangsu: 13 inventors
* San Francisco: 8 inventors
* San Francisco: 12 inventors
* Germantown: 6 inventors
* Germantown: 6 inventors
* Zürich-Schlieren: 5 inventors
* Zürich-Schlieren: 5 inventors
* Boston: 4 inventors
* Boston: 4 inventors
* Gainesville: 4 inventors
* Seattle: 2 inventors
* Palo Alto: 1 inventors
* Redwood City: 1 inventors
* Santa Clara: 1 inventors
* Stanford: 1 inventors
* Borth: 1 inventors
* Huddersfield: 1 inventors


[[Category:Molecular Computing]]
[[Category:Molecular Computing]]
[[Category:Patent Application Trends by Technology in 2025]]
[[Category:Patent Application Trends by Technology in 2025]]

Latest revision as of 05:42, 4 June 2025

Molecular Computing Patent Application Filing Activity

Molecular Computing patent applications in 2025

Top Technology Areas in Molecular Computing

Top CPC Codes

Top Companies in Molecular Computing 2025

File:Top Companies in Molecular Computing.png

The Regents of the University of California

INNOVENT CELLS PHARMACEUTICALS (SUZHOU) CO., LTD.

Molecular Partners AG

CZ Biohub SF, LLC

THE GENERAL HOSPITAL CORPORATION

University of Washington

University of Florida Research Foundation, Incorporated

  • Number of Molecular Computing patents: 1
  • Top CPC codes:
    • A61K40/429 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
    • A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
    • A61K40/11 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
  • Recent patents:

PRECIGEN, INC.

DNA 2 Ascendancy AB

INNOVENT CELLS PHARMACEUTICALS (SU ZHOU) CO., LTD.

New Companies in Molecular Computing (Last Month)

File:New Companies in Molecular Computing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Molecular Computing

Top Companies in Emerging Molecular Computing Technologies 2025

Top Inventors in Molecular Computing

Wei XU

Huafeng WEI

Wendell A. Lim of San Francisco CA (US)

Hideho Okada of San Francisco CA (US)

Kole T. Roybal of San Francisco CA (US)

Joseph H. Choe of San Francisco CA (US)

Payal B. Watchmaker of San Francisco CA (US)

James A. WELLS of San Francisco CA (US)

Zachary B. HILL of San Francisco CA (US)

Alexander J. MARTINKO of San Francisco CA (US)

Diana Binia DAROWSKI

Dan XU

Ying YAO

Bianka PRINZ

Nadthakarn BOLAND

James GEOGHEGAN

Simon Fontaine

Andreas Bosshart

Bernd Schlereth

Daniel Steiner

Marcel Walser

Hyongsok Soh of Palo Alto CA (US)

Alexander M. Yoshikawa of Redwood City CA (US)

Alexandra E. Rangel of Santa Clara CA (US)

Amani Hariri of Stanford CA (US)

Max Jan of Boston MA (US)

Quinlan L. Sievers of Boston MA (US)

Benjamin Ebert of Boston MA (US)

Marcela Maus of Boston MA (US)

Cole DeForest of Seattle WA (US)

Barry Badeau of Seattle WA (US)

Loic Deleyrolle of Gainesville FL (US)

Duane Mitchell of Gainesville FL (US)

Jianping Huang of Gainesville FL (US)

Linchun Jin of Gainesville FL (US)

Mark Anton HELD of Germantown MD (US)

Xinhua ZHAO of Germantown MD (US)

Lily Yuin CHAO of Germantown MD (US)

Na TRINH of Germantown MD (US)

James KEALEY of Germantown MD (US)

Kevin Lee DIETZEL of Germantown MD (US)

Taylor Hanh NGUYEN of San Francisco CA (US)

Galen DODS of San Francisco CA (US)

Hana EL-SAMAD of San Francisco CA (US)

Andrew H. NG of San Francisco CA (US)

Ross D. KING

Konstantin KOROVIN

Shengjie GUO

Jianan CHEN

Guozhi CHEN

Top Collaborations in Molecular Computing

Top US States for Molecular Computing Inventors


Top Cities for Molecular Computing Inventors

  • Suzhou, Jiangsu: 13 inventors
  • San Francisco: 12 inventors
  • Germantown: 6 inventors
  • Zürich-Schlieren: 5 inventors
  • Boston: 4 inventors
  • Gainesville: 4 inventors
  • Seattle: 2 inventors
  • Palo Alto: 1 inventors
  • Redwood City: 1 inventors
  • Santa Clara: 1 inventors
  • Stanford: 1 inventors
  • Borth: 1 inventors
  • Huddersfield: 1 inventors
Retrieved from "https://wikipatents.org/index.php?title=Molecular_Computing_Patent_Application_Trends_2025&oldid=615350"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.